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UNDERSTANDING THE STRUCTURE OF AMYLOID FIBRILS USING ATOMIC FORCE 
MICROSCOPY (AFM) TO DESIGN NEW THERAPEUTIC STRATEGIES FOR 
NEURODEGENERATIVE DISEASES 
 
Sumeyra Gokalp, MS and Michelle Foster, PhD 
Department of Chemistry, University of Massachusetts Boston 
 
Amyloid fibrils are misfolded proteins that are irreversible once they are formed. In human 
beings, there are different kinds of proteins that form into amyloid fibrils and are associated with 
several degenerative diseases. For example, insulin, Huntington, Amyloid β-42 and α- synuclein 
proteins are linked with Type-2 Diabetes, Huntington’s, Alzheimer’s and Parkinson’s diseases, 
respectively. The mechanism for the misfolding and creation of the fibrils is thought to be the 
same for all of these proteins. Hen Egg White Lysozyme (HEWL) is a low-cost and widely 
recognized model protein to work with to help us understand the mechanisms of amyloid 
fibrillogenesis. The aim of this project is to denature the lysozyme protein using different kinds of 
methods, acidic and basic conditions. We will investigate the mechanisms of growth of 
lysozyme amyloid fibrils under these conditions over a two-week period using Atomic Force 
Microscopy (AFM). AFM provides a topographical image of the fibrils bound to a mica substrate. 
Examining the AFM images taken after different incubation times and thus at various stages of 
growth, will allow us to analyze their morphological parameters, such as length, width, and 
height, to better understand the growth mechanisms of amyloid fibrils. It is thought that a drug 
can be designed to be able to stop progression of the disease by removing the amyloid fibrils or 
preventing further buildup. Knowing the structure of the amyloid fibrils makes it possible to 
understand how it contributes to neurodegenerative diseases and how it could be treated with a 
specific drug or other therapy.  
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